| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6572ff5df928fd17340eb2a8cb6d8502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2cf540ce39985ac87786af2c780ffe96 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 |
| filingDate |
2018-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51908bfd395a6e2e4c410128c8d7e620
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fb9857f7680d4d4bfdda626f1955fa6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86b803d99e58048548c7e7f08b3fa0b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbdd456fa4888275f4fa79e558aab436 |
| publicationDate |
2019-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-I672302-B |
| titleOfInvention |
New crystal form of BCL-2 inhibitor, preparation method thereof and pharmaceutical composition containing the same |
| abstract |
The present invention provides a crystalline form II of Compound A. HCl: And a pharmaceutical composition comprising the same, characterized by X-ray powder diffraction pattern and solid state 13 C NMR spectroscopy. |
| priorityDate |
2017-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |